All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Listed as ongoing, but also has a completion date and reported results | 2004-002015-86 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Scalp Psoriasis. | 2005-09-08 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2004-002152-33 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle and Calcipotriol in the Gel Vehicle in Scalp Psoriasis. A phase III study comparing a gel con... | 2005-08-30 | bad-data |
| Reported results | 2004-002687-14 | Fucidin® Cream in the Treatment of Impetigo A phase IV study comparing clinical and bacteriological efficacy of Fucidin® cream with Fucidin® cream vehicle in the treatment of impetigo in paediatric pa... | 2005-03-11 | due-trials |
| Reported results | 2004-002861-19 | Long-term treatment of Scalp Psoriasis with Calciptriol plus Betamethasone dipropionate gel. A phase III safety study of a new gel containing calcipotriol 50mcg/g plus betamethasone 0.5 mg/g (as dipro... | 2006-09-22 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2004-004577-28 | Different treatment regimens of calcipotriol cream and combination (calcipotiol/betamethasone dipropionate) ointment in psoriasis vulgaris | 2005-12-13 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2005-002270-29 | Safety profile of innohep versus subcutaneous unfractionated Heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis | 2008-04-08 | bad-data |
| Reported results | 2005-002864-27 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients with Scalp Psoriasis. A phase III study comparing a gel containing calcipotriol 50 mcg/g plus b... | 2006-05-17 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2005-003215-78 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Psoriasis Vulgaris. | 2006-05-08 | bad-data |
| Reported results | 2006-001472-20 | LEO19123 Cream in the Treatment of Atopic Dermatitis | 2007-08-24 | due-trials |
| Reported results | 2006-002686-39 | LEO19123 Cream in the Treatment of Hand Eczema | 2007-07-11 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2006-002873-35 | Exploratory efficacy and safety, pharmacokinetics and dose-finding study of ATryn® (antithrombin alfa) in patients with disseminated intravascular coagulation associated with severe sepsis | 2009-03-18 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2007-003365-41 | Calcipotriol Plus Hydrocortisone Ointment Compared with Tacalcitol Ointment in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment conta... | 2009-06-18 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2007-004782-18 | Calcipotriol Plus Hydrocortisone in Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g ... | 2010-01-11 | bad-data |
| Ongoing, reported early | 2007-005463-10 | A plaque test comparing three marketed products and two products in development and a vehicle control for the treatment of psoriasis vulgaris | not-yet-due | |
| Reported results | 2007-005501-22 | Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas | 2009-12-08 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2008-005456-24 | Safety and Efficacy of Calcipotriol plus Betamethasone Dipropionate Gel in Adolescent Patients (Aged 12 to 17 Years) with Scalp Psoriasis | 2012-10-15 | bad-data |
| Ongoing, reported early | 2008-005487-13 | A plaque test comparing 4 steroids with Daivobet® ointment and a vehicle control for the treatment of psoriasis vulgaris | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2009-010963-18 | A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g (LEO 80190 ointment) with hydrocortisone 10 mg/g ointment, both applied once daily in the treatment o... | 2010-06-08 | bad-data |
| Reported results | 2009-013792-22 | A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pimecr... | 2010-06-30 | due-trials |
| Ongoing, reported early | 2009-017858-12 | A phase 2a proof of concept study comparing three doses of an oral solution of LEO 22811 with a placebo oral solution for the treatment of psoriasis vulgaris | not-yet-due | |
| Reported results | 2009-018141-20 | A Phase 3 Study of Subcutaneous Innohep 20,000 anti-Xa IU/ml for the Treatment of Venous Thromboembolism (VTE) in Cancer Patients | 2014-06-25 | due-trials |
| Completed, but no date Terminated | 2010-021941-38 | LEO 90110 ointment in the treatment of psoriasis vulgaris | bad-data | |
| Reported results | 2011-005018-13 | Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp | 2014-02-04 | due-trials |
| Reported results Terminated | 2011-006275-20 | A phase II exploratory study evaluating the efficacy of topical cromoglicate solution(20mg/ml) compared to topical solution vehicle in the treatment of mastocytosis | 2013-03-05 | due-trials |
| Reported results | 2012-000253-30 | An exploratory study evaluating the efficacy of cromoglicate cream compared to cream vehicle in the treatment of itch in psoriasis | 2013-04-11 | due-trials |
| Reported results | 2012-002863-88 | A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen with Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas with Actinic Keratosis on Face/Scalp and Trunk/Extremities | 2014-01-22 | due-trials |
| Listed as ongoing, but also has a completion date | 2012-003112-31 | Risk of Squamous Cell Carcinoma on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% | 2019-07-11 | bad-data |
| Reported results | 2013-000410-38 | Topical Aprepitant in Prurigo Patients (iTAPP) | 2014-07-28 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2013-001538-16 | Effect of Calcipotriol plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 months) with Scalp and Body Psoriasis | 2018-02-13 | bad-data |
| Ongoing, reported early | 2013-004686-14 | LEO 90100 aerosol foam compared to calcipotriol plus betamethasone dipropionate gel in subjects with psoriasis vulgaris | not-yet-due | |
| Reported results | 2014-000037-23 | Clinical Study Protocol | 2015-03-06 | due-trials |
| Reported results | 2014-003072-24 | Patient insights following use of LEO 90100 aerosol foam and Daivobet® gel in subjects with psoriasis vulgaris | 2015-11-30 | due-trials |
| Reported results | 2014-003218-98 | Efficacy and safety of ingenol mebutate gel 0.015% compared to diclofenac sodium gel 3% in subjects with actinic keratoses on the face or scalp. | 2016-07-13 | due-trials |
| Reported results | 2014-004465-24 | Safety and efficacy of repeat use of Picato® 0.05% in the treatment of anogenital warts | 2015-11-26 | due-trials |
| Ongoing, reported early | 2014-004759-30 | A psoriasis plaque test trial with LP0113 spray in patients with psoriasis vulgaris | not-yet-due | |
| Reported results | 2015-000839-33 | Safety and Effect of LEO 90100 aerosol foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) with Plaque Psoriasis | 2018-03-28 | due-trials |
| Ongoing, reported early | 2015-001798-41 | A psoriasis plaque test trial with LEO 90100 compared to Betesil® in patients with psoriasis vulgaris | not-yet-due | |
| Reported results | 2015-002098-40 | A Phase 2a, Proof of Concept Trial, testing twice daily application of LEO 124249 ointment 30mg/g in the treatment of mild to moderate inverse psoriasis | 2016-09-19 | due-trials |
| Reported results | 2015-002449-71 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up | 2017-11-14 | due-trials |
| Reported results | 2015-002450-12 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up | 2017-08-10 | due-trials |
| Reported results | 2015-002451-10 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up | 2017-09-06 | due-trials |
| Reported results | 2015-002452-27 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up | 2017-10-27 | due-trials |
| Reported results | 2015-005279-25 | LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris | 2017-07-06 | due-trials |
| Listed as ongoing, but also has a completion date | 2016-000556-95 | LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris | 2019-06-27 | bad-data |
| Completed, report not yet due | 2016-003867-21 | A phase 4 trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate to severe plaque psoriasis | 2019-05-02 | not-yet-due |
| Listed as ongoing, but also has a completion date | 2016-004200-65 | A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... | 2019-10-10 | bad-data |
| Listed as ongoing, but also has a completion date | 2016-004201-13 | A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... | 2019-08-15 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2017-000228-85 | Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis treated with ingenol disoxate gel 0.018% or 0.037%, or vehicle | 2018-01-31 | bad-data |
| Ongoing | 2017-002065-21 | A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroid in subjects with moderate-to-severe atopic ... | not-yet-due | |
| Reported results Terminated | 2017-002720-24 | Efficacy of twice daily application of LEO 124249 ointment 30 mg/g for 12 | 2018-05-16 | due-trials |
| Not reported Terminated | 2017-004508-23 | Capture of LEO 90100 medication usage with digital tracker and evaluation of efficacy in patients with psoriasis | 2018-06-11 | due-trials |
| Other | 2017-005143-33 | A randomised, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate the efficacy, safety, and tolerability of tralokinumab monotherapy in adolescent subjects with moderate-t... | not-yet-due | |
| Ongoing | 2018-000746-19 | An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clin... | not-yet-due | |
| Ongoing | 2018-000747-76 | A randomised, double-blind, placebo-controlled, parallel-group, multi-centre, phase 3 trial investigating the efficacy, safety, and tolerability of tralokinumab administered in combination with topica... | not-yet-due | |
| Ongoing | 2018-000900-40 | A phase 2b, double-blind, randomised, 5-arm, vehicle-controlled, dose-ranging trial to evaluate the efficacy and safety of twice daily topical application of delgocitinib cream 1, 3, 8, and 20 mg/g fo... | not-yet-due | |
| Ongoing | 2018-003615-22 | Efficacy and safety of twice-daily application of delgocitinib cream 20 mg/g for 6 weeks in subjects with active discoid lupus erythematosus. A phase 2a exploratory, randomised, double-blind, vehicle-... | not-yet-due |